Correlation Between DiaMedica Therapeutics and ABPRO P

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and ABPRO P at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and ABPRO P into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and ABPRO P, you can compare the effects of market volatilities on DiaMedica Therapeutics and ABPRO P and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of ABPRO P. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and ABPRO P.

Diversification Opportunities for DiaMedica Therapeutics and ABPRO P

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between DiaMedica and ABPRO is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and ABPRO P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABPRO P and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with ABPRO P. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABPRO P has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and ABPRO P go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and ABPRO P

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.78 times more return on investment than ABPRO P. However, DiaMedica Therapeutics is 1.28 times less risky than ABPRO P. It trades about 0.08 of its potential returns per unit of risk. ABPRO P is currently generating about -0.11 per unit of risk. If you would invest  275.00  in DiaMedica Therapeutics on September 12, 2024 and sell it today you would earn a total of  268.00  from holding DiaMedica Therapeutics or generate 97.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.6%
ValuesDaily Returns

DiaMedica Therapeutics  vs.  ABPRO P

 Performance 
       Timeline  
DiaMedica Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
ABPRO P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABPRO P has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

DiaMedica Therapeutics and ABPRO P Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DiaMedica Therapeutics and ABPRO P

The main advantage of trading using opposite DiaMedica Therapeutics and ABPRO P positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, ABPRO P can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABPRO P will offset losses from the drop in ABPRO P's long position.
The idea behind DiaMedica Therapeutics and ABPRO P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume